Source: Eur Respir Monogr 2016; 71: 97-105
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Oisin J. O'Connell, Jim J. Egan. The evaluation of disease severity/staging for prognosis. Eur Respir Monogr 2016; 71: 97-105

Member's Comments

No comment yet.

Related content which might interest you: Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Interstitial lung disease: improving classification and prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Time lost for diagnostics of lung carcinoma related to disease stage and prognosis Source: Eur Respir J 2004; 24: Suppl. 48, 297s Year: 2004 Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 The experience of long-term prognosis evaluation of childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 164s Year: 2005 COPD detected with screening: impact on patient management and prognosis Source: Eur Respir J 2014; 44: 1571-1578 Year: 2014 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 281-282 Year: 2016 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 279-281 Year: 2016 The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007 Clinical features and prognosis of Chinese sarcoidosis patients. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Pulmonary function evaluation in advanced Parkinson‘s disease Source: Eur Respir J 2006; 28: Suppl. 50, 201s Year: 2006 Sarcoidosis: imagiological findings and their impact on the disease outcome Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006 When and how to communicate the prognosis in a chronic respiratory disease Source: International Congress 2017 – End-of-life care of the respiratory patients Year: 2017 CPET for prognosis assessment Source: ERS Skills course - Clinical exercise testing: advanced Year: 2018